Amines & Plasticizers Ltd. (BSE: 506248) is a Mumbai, Maharashtra-based company in the Industrial Organic Chemicals industry. With a market capitalisation of ₹774 Cr, it ranks #1,703 by market cap among the 6,189 Indian listed companies on FinBizNet, and #4 of 19 in Industrial Organic Chemicals. At ₹140.65 (as of 26 Oct 2026), the share price is 39.6% below its 52-week high of ₹232.99 and 10.7% above its 52-week low of ₹127.00. The share price is down 32.9% over one year and down 28.0% over three months.
| Current Price | ₹140.65 |
|---|---|
| Market Cap | ₹774 Cr |
| BSE Code | 506248 |
| Sector | Materials > Chemicals > Commodity Chemicals |
| Sub-Industry | Commodity Chemicals > Industrial Organic Chemicals |
| P/E Ratio | 21.2 |
| Return on Equity | 13.26% |
| Return on Assets | 8.08% |
| 52-Week Range | ₹127.00 – ₹232.99 |
| 1-Year Price Change | -32.9% |
| 3-Month Price Change | -28.0% |
| Beta (1Y) | 0.26 |
| Dividend Yield | 0.36% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.amines.com |
| Revenue | ₹151 Cr |
|---|---|
| Net Profit | ₹9 Cr |
| Net Margin | 6.3% |
| EPS (Basic) | ₹1.72 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Amines & Plasticizers Limited manufactures and sells specialty chemicals in India. The company offers alkyl alkanol amines, including methyl monoethanolamine, methyl diethanolamine, di-methyl ethanolamine, di-ethyl ethanolamine, ethyl monoethanolamine, ethyl diethanolamine, mono-n-propyl monoethanolamine, mono-n-propyl diethanolamine, mono-n-butyl ethanolamine, mono-n-butyl diethanolamine, di-butyl ethanolamine, poly ethanolamine, tertiary butyl monoethanolamine, and tertiary butyl diethanolamine. It also offers alkanolamines, such as triisopropanolamine, monoethanolamine, diethanolamine, triethanolamine-tech, triethanolamine-pure, and diethanolamine LFG products, as well as morpholine and substituted morpholines comprising morpholine, N-methyl morpholine, N-methyl morpholine oxide, N-ethyl morpholine, N-formyl morpholine, hydroxy ethyl morpholine, N-acetyl morpholine, and N-butyl morpholine. In addition, the company provides specialty ethylene oxide/propylene oxide products that inclu
1. Chemical Manufacturing-This segment engages in manufacturing of organic chemicals/amines/gas treating solvents. 2. Technical & Engineering Services-0 3. Inter Segment-This segment undertakes fabrications jobs. 4. Software-This segment engages in the development of software.
1. Chemical Manufacturing-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| J.G.Chemicals Limited | ₹2,250 Cr | 34.2 | 13.52% | ₹316 Cr | +41.1% |
| India Glycols Ltd. | ₹1,927 Cr | 6.3 | 11.28% | ₹2,988 Cr | -71.2% |
| I G Petrochemicals Ltd. | ₹1,563 Cr | 704 | 0.17% | ₹618 Cr | +21.0% |
| Amines & Plasticizers Ltd. | ₹774 Cr | 21.2 | 13.26% | ₹151 Cr | -32.9% |
| Agarwal Industrial Corporation Ltd | ₹485 Cr | 11.1 | 6.62% | ₹433 Cr | -63.9% |
| Mangalam Organics Ltd | ₹400 Cr | 15.5 | 8.42% | ₹179 Cr | -4.9% |
| Andhra Petrochemicals Ltd. | ₹313 Cr | -20 | -3.05% | — | -28.5% |
| India Gelatine & Chemicals Ltd. | ₹254 Cr | 10.1 | 13.75% | ₹46 Cr | +7.7% |
| Diamines And Chemicals Ltd | ₹232 Cr | -17.7 | -8.02% | ₹14 Cr | -22.0% |
Listed by market capitalisation. Ratios are shown for context only.
Amines & Plasticizers Ltd. is trading at ₹140.65, with a market capitalisation of ₹774 Cr.
Amines & Plasticizers Ltd. operates in the Materials > Chemicals > Commodity Chemicals space (Commodity Chemicals > Industrial Organic Chemicals).
Amines & Plasticizers Ltd. has a P/E of 21.2 and a return on equity of 13.26%.
Amines & Plasticizers Ltd. is listed on the BSE under the scrip code 506248.
Amines & Plasticizers Ltd.'s share price is down 32.9% over one year and down 28.0% over three months. Its 52-week range is ₹127.00 to ₹232.99.
In Q1 FY27, Amines & Plasticizers Ltd. reported revenue of ₹151 Cr and net profit of ₹9 Cr, with basic EPS of ₹1.72 (consolidated, parsed from the company's exchange filing).
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.